Chemed Corp president and CEO Kevin McNamara sells $1.08 million in stock
Investing.com ·
Chemed Corp president and CEO Kevin McNamara sells $1.08 million in stock
Kevin J. McNamara, president and CEO of Chemed Corp (NYSE:CHE), sold 2,000 shares of the company’s capital stock for a total value of $1,075,800. The transactions, which occurred on November 3, 2026, took place at prices ranging from $532.34 to $546.52 per share. The sale comes as the stock trades near its 52-week high of $562.24, following a strong 26% gain over the past six months. According to InvestingPro analysis, the company appears undervalued at current levels, with a Fair Value suggesting upside potential.
Following these sales, Mr. McNamara directly holds 82,220 shares of Chemed Corp capital stock. The reported beneficial ownership reflects a correction of an administrative error from a July 31, 2026, filing, which increased the number of shares by 19,802 to include shares that were not captured in an option conversion calculation. For deeper insights, InvestingPro offers a comprehensive Pro Research Report on CHE, one of 1,400+ US equities covered with expert analysis and actionable intelligence.
In other recent news, Chemed Corp. reported its third-quarter 2026 earnings, surpassing Wall Street expectations. The company’s adjusted diluted earnings per share reached $6.75, exceeding the forecast of $6.44. Additionally, Chemed’s revenue was reported at $690.9 million, above the anticipated $685.04 million. This performance was attributed to strong growth at its VITAS hospice unit and steady revenue gains at Roto-Rooter. These results highlight Chemed’s ability to exceed both profit and revenue estimates, with earnings per share coming in 4.8% above forecasts.
Read the full story at Investing.com · All coverage of this story